Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Equity Average (2016 - 2025)

Creative Medical Technology Holdings has reported Equity Average over the past 15 years, most recently at $6.6 million for Q4 2025.

  • Quarterly Equity Average rose 1.69% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 1.69% year-over-year, with the annual reading at $6.9 million for FY2025, 16.9% down from the prior year.
  • Equity Average was $6.6 million for Q4 2025 at Creative Medical Technology Holdings, up from $6.2 million in the prior quarter.
  • Over five years, Equity Average peaked at $22.6 million in Q3 2022 and troughed at -$21.1 million in Q1 2021.
  • The 5-year median for Equity Average is $7.9 million (2024), against an average of $8.1 million.
  • Biggest five-year swings in Equity Average: plummeted 275.39% in 2021 and later surged 4285.9% in 2022.
  • Tracing CELZ's Equity Average over 5 years: stood at $4.9 million in 2021, then skyrocketed by 284.96% to $19.0 million in 2022, then crashed by 40.86% to $11.2 million in 2023, then plummeted by 42.51% to $6.4 million in 2024, then increased by 1.69% to $6.6 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $6.6 million, $6.2 million, and $7.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.